Skip to content

Evaluation of Safety and Hair Removal Effect of a Skin Care Product

To evaluate the in vivo safety and efficacy of the skin care formulations in terms of hair removal effect on healthy human subjects - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101009
Enrollment
33
Registered
2026-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NAMYAA Hair Removal Cream: NAMYAA Hair Removal Cream will be applied to the right underarm as per product instructions, kept for at least 5 minutes, and then removed using a spatula. Th

Sponsors

RG Biocosmetics
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Indian male and female subjects 2)Healthy subjects 3)Skin is healthy on the studied anatomic unit 4)Having terminal hair in the areas to be treated. 5)Having a habit of using hair removal cream and hair removal spray

Exclusion criteria

Exclusion criteria: 1)For Females: Being pregnant or breastfeeding or having stopped breastfeeding in the past three months. 2)Having refused to give his/her assent by not signing the consent form 3)Taking part in another study liable to interfere with this study 4)Being allergic to use of powder, removal cream/ spray on study site. 5)Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months) 6)Having a progressive asthma (either under treatment or last fit in the last 2 years) 7)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis) 8)Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 9)Being epileptic. 10)Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). 11)Having cutaneous hypersensitivity. 12)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products. 13)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. 14)Having changed cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit.

Design outcomes

Primary

MeasureTime frame
Safety and hair removal effectTimepoint: Baseline, 5 Minutes after product appliaction for cream, 7 Minutes after product application for spray, 30 minutes and 1 hour after application

Secondary

MeasureTime frame
NilTimepoint: NA

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

niharika@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026